The House of Representatives last week passed a bill (387 to 5 vote) that would reauthorize the Food and Drug Administration’s user fee programs and a
Continue Reading House Passes FDA Reauthorization Bill
Mass Tort Defense
Defense of Mass Tort Claims, Class Actions, and Significant Product-Based Litigation